NASDAQ:NNNN • KYG0367B1059
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANBIO BIOTECHNOLOGY LTD (NNNN).
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 23.545M 431.66% | 6.712M -71.49% | 8.185M 21.95% | |
| EBITDA YoY % growth | 10.202M 315.40% | 1.973M -80.66% | N/A | |
| EBIT YoY % growth | 10.196M 315.15% | 1.961M -80.77% | 1.995M 1.76% | |
| Operating Margin | 43.30% | 29.21% | 24.38% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
ANBIO BIOTECHNOLOGY LTD (NNNN) will report earnings on 2026-04-27.